Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 2
Submit an article Journal homepage
134
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis

Paolo MusiuDepartment of Translational and Precision Medicine, Sapienza University, Rome, ItalyCorrespondence[email protected]
,
Luisa QuattrocchiDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Walter BarberiDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Irene Della StarzaDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Loredana EliaDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Lucia Anna De NoviDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Luigi PetrucciDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Giulia De LucaDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
,
Alice Di RoccoDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
&
Ursula La RoccaDepartment of Translational and Precision Medicine, Sapienza University, Rome, Italy
 show all
Pages 499-502 | Received 21 Jul 2021, Accepted 16 Sep 2021, Published online: 25 Oct 2021

References

  • Hertenstein B, Hambach L, Bacigalupo A, et al. Chronic leukaemia working party of the European group for blood and marrow transplantation. Development of leukemia in donor cells after allogeneic stem cell transplantation – a survey of the European group for blood and marrow transplantation (EBMT). Haematologica. 2005;90(7):969–975.
  • Nagamura-Inoue T, Kodo H, Takahashi TA, et al. Four cases of donor cell-derived AML following unrelated cord blood transplantation for adult patients: experiences of the Tokyo cord blood bank. Cytotherapy. 2007;9(8):727–728.
  • Boyd CN, Ramberg RC, Thomas ED. The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res. 1982;6(6):833–837.
  • Faderl S, Verstovsek S, Cortes J, et al. Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older. Blood. 2006;108(1):45–51.
  • Delarue R, Haioun C, Ribrag V, et al. CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the groupe d'Etude des lymphomes de l'Adulte. Blood. 2013;121(1):48–53.
  • Wang ML, Lee H, Chuang H, et al. Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial. Lancet Oncol. 2016;17(1):48–56.
  • Fialkow PJ, Thomas ED, Bryant JI, et al. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet. 1971;1(7693):251–255.
  • Suárez-González J, Martínez-Laperche C, Kwon M, et al. Donor cell-derived hematologic neoplasms after hematopoietic stem cell transplantation: a systematic review. Biol Blood Marrow Transplant. 2018;24(7):1505–1513.
  • Berg KD, Brinster NK, Huhn KM, et al. Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med. 2001;345(20):1458–1463.
  • Weigert O, Kopp N, Lane AA, et al. Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Cancer Discov. 2012;2(1):47–55.
  • Christian B, Zhao W, Hamadani M, et al. Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor. J Clin Oncol. 2010;28(31):e629–e632.
  • Flynn CM, Kaufman DS. Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood. 2007;109(7):2688–2692.
  • Mauro FR, Giammartini E, Gentile M, et al. Clinical features and outcome of familial chronic lymphocytic leukemia. Haematologica. 2006;91(8):1117–1120. PMID: 16885053.
  • Del Giudice I, Mauro FR, De Propris MS, et al. Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients. Blood. 2009;114(13):2848–2849.
  • Liu Z, Liu H, Shi M, et al. Donor HSCs with a preexisting ASXL1-mutation led to the development of FLT3-ITD positive AML in the donor and FLT3-ITD negative AML in the recipient after unrelated transplant. Bone Marrow Transplant. 2018;53(4):499–502.
  • Herold S, Kuhn M, Bonin MV, et al. Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient. Leukemia. 2017;31(7):1637–1640.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.